Thiazole derivative and leukotriene antagonist containing the same as
the effective ingredients
    1.
    发明授权
    Thiazole derivative and leukotriene antagonist containing the same as the effective ingredients 失效
    噻唑衍生物和含有与有效成分相同的白三烯拮抗剂

    公开(公告)号:US4902700A

    公开(公告)日:1990-02-20

    申请号:US279225

    申请日:1988-11-28

    摘要: Disclosed are a thiazole derivative represented by the following formula, a pharmaceutically acceptable salt thereof and leukotriene antagonist containing the same as the active ingredients: ##STR1## wherein R.sub.1 and R.sub.2 each independently represent a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, a lower alkoxycarbonyl group or a substituted or unsubstituted phenyl group or cooperatively represent a tetramethylene group corresponding to a fused cyclohexane ring or a butadienylene group which is unsubstituted or substituted with a halogen atom, a lower alkoxy group, a lower alkoxycarbonyl group or an alkyl group having 1 to 3 carbon atoms corresponding to a fused benzene ring; R.sub.3, R.sub.4, R.sub.5 and R.sub.6 each independently represent a hydrogen atom, a hydroxyl group, a lower alkoxy group, an alkyl group having 1 to 3 carbon atoms or a halogen atom; A represents a linking group having 2 to 4 chain members; B represents a linking group having 2 to 5 chain members; and Q represents a carboxyl group, a lower alkoxy group, a hydroxyl group, an alkoxycarbonyl group having 2 to 6 carbon atoms or a 5-tetrazolyl group.

    摘要翻译: 公开了由下式表示的噻唑衍生物,其药学上可接受的盐和含有与活性成分相同的白三烯拮抗剂:其中R 1和R 2各自独立地表示氢原子,具有1至8个碳原子的烷基 低级烷氧基羰基或取代或未取代的苯基,或协同表示对应于未被取代或被卤素原子,低级烷氧基,低级烷氧基羰基或烷基取代的稠环己烷环或丁二烯基的四亚甲基 对应于稠合苯环的具有1至3个碳原子的基团; R 3,R 4,R 5和R 6各自独立地表示氢原子,羟基,低级烷氧基,碳原子数1〜3的烷基或卤素原子。 A表示具有2至4个链成员的连接基团; B表示具有2至5个链成员的连接基团; Q表示羧基,低级烷氧基,羟基,碳原子数2〜6的烷氧基羰基或5-四唑基。

    .gamma.-butyrolactone derivatives, process for preparing the same and
immunomodulating compositions containing the same as active ingredients
    3.
    发明授权
    .gamma.-butyrolactone derivatives, process for preparing the same and immunomodulating compositions containing the same as active ingredients 失效
    γ-丁内酯衍生物,其制备方法和含有该活性成分的免疫调节组合物

    公开(公告)号:US4613613A

    公开(公告)日:1986-09-23

    申请号:US647979

    申请日:1984-09-06

    摘要: A .gamma.-butyrolactone derivative represented by the following formula: ##STR1## wherein R.sup.1 represents a hydrogen atom, a straight or branched alkyl group having 1-8 carbon atoms, a phenyl group; R.sup.2 and R.sup.3 may be the same or different and each represents a hydrogen atom, a straight or branched alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-10 carbon atoms, a benzyl group, a phenyl group, a phenyl group substituted with a substituent selected from the group consisting of a halogen atom, an alkoxy group, a nitro group, an amino group, an alkyl group having 1-4 carbon atoms, a nitrile group and an alkoxycarbonyl group; R.sup.2 and R.sup.3 may be linked to form an alkylene group having 4-6 carbon atoms; X represents a hydrogen atom, a straight or branched alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-10 carbon atoms, a benzyl group or a substituent represented by the formula ##STR2## (wherein R.sup.4 represents a straight or branched alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-10 carbon atoms, a benzyl group, a phenyl group or a phenyl group substituted with a substituent selected from the group consisting of a halogen atom, an alkoxy group, a nitro group, an alkylthio group, a nitrile group, an alkoxycarbonyl group and an alkyl group having 1-4 carbon atoms) or a salt thereof. The invention also provides an immunomodulating composition wherein the aforedescribed compound is the active component.

    摘要翻译: 由下式表示的γ-丁内酯衍生物:其中R1表示氢原子,具有1-8个碳原子的直链或支链烷基,苯基; R2和R3可以相同或不同,各自表示氢原子,具有1-8个碳原子的直链或支链烷基,具有3-10个碳原子的环烷基,苄基,苯基,苯基 被选自卤素原子,烷氧基,硝基,氨基,具有1-4个碳原子的烷基,腈基和烷氧羰基组成的组中的取代基取代; R2和R3可以连接形成具有4-6个碳原子的亚烷基; X表示氢原子,具有1-8个碳原子的直链或支链烷基,具有3-10个碳原子的环烷基,苄基或由式“IMAGE”表示的取代基(其中R4表示直链或支链 具有1-8个碳原子的烷基,具有3-10个碳原子的环烷基,苄基,苯基或被选自卤素原子,烷氧基,硝基的取代基取代的苯基 基团,烷硫基,腈基,烷氧基羰基和具有1-4个碳原子的烷基)或其盐。 本发明还提供一种免疫调节组合物,其中上述化合物是活性成分。